Cardiovascular Diseases: Biomarker-Guided Therapy and Clinical Management
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: 30 April 2024 | Viewed by 1097
Special Issue Editors
Interests: molecular mechanism and intervention target of cardiovascular remodeling
Interests: basic and clinical study of acute and critical cardiovascular disease including acute myocardial infarction, valvular heart disease, heart failure, aortic dissection and arrhythmia
Interests: basic research in the inflammation and immunity, and the pathogenesis of vascular diseases, such as atherosclerosis and abdominal aortic aneurysm
Special Issue Information
Dear Colleagues,
We invite you to participate in this Special Issue of JCM on “Cardiovascular Diseases: Biomarker-Guided Therapy and Clinical Management”. As is well-known, despite ongoing advances in prevention, diagnosis and treatment, cardiovascular disease (CVD) is the leading cause of death worldwide. Thus, it is necessary to find sensitive and specific biomarkers to promote early diagnostic and prognostic evaluation of CVD. Several biomarkers have been investigated as potential predictors of CVD, such as CRP, troponin and BNP. Numerous other biomarkers pertaining to diagnosis, prognosis, and risk prediction have been identified, but few have been used in clinical practice. In this Special Issue of JCM, we aim to better interpret the role of currently available biomarkers and discover other candidate biomarkers. Both original research papers and comprehensive review papers in the following areas are welcome:
1) The use of biomarkers in CVD severity.
2) The use of biomarkers for monitoring the progression of CVD.
3) The role of biomarkers in risk stratification.
4) The role of biomarkers in therapeutic management.
5) The use of biomarkers in postoperative outcome prediction.
Dr. Jianmin Yang
Dr. Chuanbao Li
Dr. Weidong Qin
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiovascular disease
- biomarker
- therapy
- risk stratification
- diagnosis
- prognosis